Molecular Diagnostics Market Size is Valued at USD 13.01 Billion in 2024, and is Projected to Reach USD 26.34 Billion by 2032, Growing at a CAGR of 9.22% From 2025-2032.
Advancements in genomics and personalized medicine are driving significant expansion in the molecular diagnostics market. This market includes technologies such as PCR, next-generation sequencing, and microarrays, which are employed to detect and monitor genetic disorders, infectious diseases, and malignancies. The market is expanding due to the increasing demand for rapid and accurate diagnostic techniques, as well as the increasing prevalence of these diseases.